Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study

被引:7
作者
Kelly, Mary Kate [1 ]
Grundmeier, Robert W. [1 ,2 ]
Stephens-Shields, Alisa J. [3 ]
Localio, Russell [3 ]
Shone, Laura P. [4 ,5 ]
Wright, Margaret [4 ,5 ]
Steffes, Jennifer [4 ,5 ]
Humiston, Sharon G. [6 ]
Rand, Cynthia [7 ]
Albertin, Christina [8 ]
Breck, Abigail [8 ]
Abney, Dianna E. [5 ]
McFarland, Greta [5 ]
Szilagyi, Peter G. [7 ]
Fiks, Alexander G. [1 ,5 ]
机构
[1] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
[4] Amer Acad Pediat, Primary Care Res, Itasca, IL USA
[5] Amer Acad Pediat, Pediat Res Off Settings, Itasca, IL USA
[6] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA
[7] Univ Rochester, Dept Pediat, Rochester, NY USA
[8] Univ Calif Los Angeles, Dept Pediat, Mattel Childrens Hosp, Los Angeles, CA 90024 USA
关键词
Human papillomavirus vaccine; Missed opportunities; Influenza vaccine; Primary care; ADVISORY-COMMITTEE; IMMUNIZATION; ADOLESCENTS; COVERAGE; SAFETY; RECOMMENDATIONS; IMMUNOGENICITY; US;
D O I
10.1016/j.vaccine.2020.05.090
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Little is known about missed opportunities (MOs) for HPV vaccination during primary care visits at which influenza vaccination is delivered. Methods: We extracted electronic health records for HPV vaccine-eligible 11-to-17-year-olds. We assessed the proportion of visits during which an influenza vaccine was given and an HPV vaccine was due, but not given (i.e., MOs). Results: Of 56,135 eligible visits, 57.5% represented MOs for HPV vaccination. MOs were more common at visits where an initial versus subsequent HPV vaccine dose was due (68.6% vs. 31.3%) and for acute/chronic and nurse-only visits compared to preventive visits (74.0% and 80.2% vs. 36.7%). In a multivariable model, MOs were more likely for the initial HPV dose and for non-preventive visits, but did not vary by patient sex/age. Conclusions: HPV vaccine MOs were common during visits where influenza vaccine was administered. Increasing simultaneous administration of HPV and influenza vaccines could increase HPV vaccine coverage. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5105 / 5108
页数:4
相关论文
共 20 条
[1]   Immunogenicity and safety of the 9-valent HPV vaccine in men [J].
Castellsague, X. ;
Giuliano, A. R. ;
Goldstone, S. ;
Guevara, A. ;
Mogensen, O. ;
Palefsky, J. M. ;
Group, T. ;
Shields, C. ;
Liu, K. ;
Maansson, R. ;
Luxembourg, A. ;
Kaplan, S. S. .
VACCINE, 2015, 33 (48) :6892-6901
[2]   Human Papillomavirus Vaccination: Narrative Review of Studies on How Providers' Vaccine Communication Affects Attitudes and Uptake [J].
Dempsey, Amanda F. ;
O'Leary, Sean T. .
ACADEMIC PEDIATRICS, 2018, 18 (02) :S23-S27
[3]   Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis [J].
Drolet, Melanie ;
Benard, Elodie ;
Perez, Norma ;
Brisson, Marc ;
Boily, Marie-Claude ;
Ali, Hammad ;
Baldo, Vincenzo ;
Brassard, Paul ;
Brotherton, Julia M. L. ;
Callander, Denton ;
Checchi, Marta ;
Chow, Eric P. F. ;
Cocchio, Silvia ;
Dalianis, Tina ;
Deeks, Shelley L. ;
Dehlendorff, Christian ;
Donovan, Basil ;
Fairley, Christopher K. ;
Flagg, Elaine W. ;
Gargano, Julia W. ;
Garland, Suzanne M. ;
Grun, Nathalie ;
Hansen, Bo T. ;
Harrison, Christopher ;
Herweijer, Eva ;
Imburgia, Teresa M. ;
Johnson, Anne M. ;
Kahn, Jessica A. ;
Kavanagh, Kimberley ;
Kjaer, Susanne K. ;
Kliewer, Erich V. ;
Liu, Bette ;
Machalek, Dorothy A. ;
Markowitz, Lauri ;
Mesher, David ;
Munk, Christian ;
Niccolai, Linda ;
Nygard, Mari ;
Ogilvie, Gina ;
Oliphant, Jeannie ;
Pollock, Kevin G. ;
Purrinos-Hermida, Maria Jesus ;
Smith, Megan A. ;
Steben, Marc ;
Soderlund-Strand, Anna ;
Sonnenberg, Pam ;
Sparen, Par ;
Tanton, Clare ;
Wheeler, Cosette M. ;
Woestenberg, Petra J. .
LANCET, 2019, 394 (10197) :497-509
[4]   Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System [J].
Irving, Stephanie A. ;
Groom, Holly C. ;
Stokley, Shannon ;
McNeil, Michael M. ;
Gee, Julianne ;
Smith, Ning ;
Naleway, Allison L. .
ACADEMIC PEDIATRICS, 2018, 18 (02) :S85-S92
[5]   Parents Who Decline HPV Vaccination: Who Later Accepts and Why? [J].
Kornides, Melanie L. ;
McRee, Annie-Laurie ;
Gilkey, Melissa B. .
ACADEMIC PEDIATRICS, 2018, 18 (02) :S37-S43
[6]   Ten Years of Human Papillomavirus Vaccination in the United States [J].
Markowitz, Lauri E. ;
Gee, Julianne ;
Chesson, Harrell ;
Stokley, Shannon .
ACADEMIC PEDIATRICS, 2018, 18 (02) :S3-S10
[7]  
Markowitz LE, 2014, MMWR RECOMM REP, V63, P1
[8]   Effect of Decision Support on Missed Opportunities for Human Papillomavirus Vaccination [J].
Mayne, Stephanie L. ;
duRivage, Nathalie E. ;
Feemster, Kristen A. ;
Localio, A. Russell ;
Grundmeier, Robert W. ;
Fiks, Alexander G. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2014, 47 (06) :734-744
[9]   Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices [J].
Meites, Elissa ;
Kempe, Allison ;
Markowitz, Lauri E. .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (49) :1405-1408
[10]   Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials [J].
Moreira, Edson D., Jr. ;
Block, Stan L. ;
Ferris, Daron ;
Giuliano, Anna R. ;
Iversen, Ole-Erik ;
Joura, Elmar A. ;
Kosalaraksa, Pope ;
Schilling, Andrea ;
Van Damme, Pierre ;
Bornstein, Jacob ;
Xavier Bosch, F. ;
Pils, Sophie ;
Cuzick, Jack ;
Garland, Suzanne M. ;
Huh, Warner ;
Kjaer, Susanne K. ;
Qi, Hong ;
Hyatt, Donna ;
Martin, Jason ;
Moeller, Erin ;
Ritter, Michael ;
Baudin, Martine ;
Luxembourg, Alain .
PEDIATRICS, 2016, 138 (02)